Skip to main content

Table 3 Logistic regression analyses

From: Factors influencing diagnosis and treatment of osteoporosis after a fragility fracture among postmenopausal women in Asian countries: a retrospective study

 

BMD measurement (N=837)

Osteoporosis diagnosis

Osteoporosis medication

OR

(95% CI)

OR

(95% CI)

OR

(95% CI)

Age

      

 20- 49

1.38

(0.35 -5.51)

0.6

(0.18-2.00)

N/A

 

 50-64

1.36

(0.91-2.05)

1.19

(0.77-1.84)

0.59

(0.36-0.96)

 65+

Reference

 

Reference

 

Reference

 

Fracture history

      

 Yes

0.63

(0.45-0.88)

0.80

(0.56-1.15)

1.05

(0.71-1.54)

 No

Reference

 

Reference

 

Reference

 

Fracture diagnosis timing

      

 Before index fracture

N/A

 

N/A

 

0.99

(0.64-1.52)

 During index fracture

N/A

 

N/A

 

1.38

(0.87-2.18)

 After index fracture

N/A

 

N/A

 

Reference

 

 Unknown

N/A

 

N/A

 

0.28

(0.05-1.47)

A BMD measurement

      

 Yes

N/A

 

10.1

(6.36-16.0)

1.79

(1.23-2.61)

 Unknown

N/A

 

0.06

(0.03-0.10

1.48

(0.59-3.74)

 No

N/A

 

Reference

 

Reference

 

Type of payment

      

 100% private insurance

8.19

(2.63 -25.58)

0.72

(0.20-2.54)

2.03

(0.54-7.66)

 100% social insurance

1.96

(1.09 -3.50)

0.47

(0.27-0.84)

0.18

(0.07-0.51)

 Other type of insurance

5.08

(3.11 -8.30)

2.48

(1.45-4.25)

2.45

(1.40-4.29)

 Unknown insurance

1.33

(0.62-2.83)

0.39

(0.19-0.80)

1.05

(0.38-2.92)

 Free hospital, government pay

4.13

(2.00-8.54)

1.31

(0.57-3.03)

1.56

(0.66-3.70)

 Partial self with private insurance

3.43

(1.19-9.86)

4.95

(1.51-16.21)

0.49

(0.15-1.59)

 Partial self with social insurance

3.94

(2.61 -5.95)

1.89

(1.28-2.81)

0.72

(0.45-1.15)

 100% self pay

Reference

 

Reference

 

Reference

 
  1. N/A, not applicable.